Total Payments
$4,764
2024 Payments
$72.14
Companies
17
Transactions
46
Medicare Patients
1,829
Medicare Billing
$375,437
Payment Breakdown by Category
Food & Beverage$3,335 (70.0%)
Travel$1,159 (24.3%)
Other$270.00 (5.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,335 | 42 | 70.0% |
| Travel and Lodging | $1,159 | 3 | 24.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $270.00 | 1 | 5.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alcon Laboratories Inc | $1,169 | 3 | $0 (2017) |
| Regeneron Pharmaceuticals, Inc. | $1,066 | 4 | $0 (2023) |
| Alimera Sciences, Inc. | $555.83 | 6 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $419.13 | 7 | $0 (2019) |
| Allergan Inc. | $380.24 | 3 | $0 (2019) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $350.90 | 7 | $0 (2020) |
| Genentech USA, Inc. | $215.21 | 4 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $137.82 | 2 | $0 (2023) |
| Johnson & Johnson Surgical Vision, Inc. | $117.76 | 1 | $0 (2021) |
| ABBVIE INC. | $100.00 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $72.14 | 3 | Mallinckrodt Hospital Products Inc. ($52.80) |
| 2023 | $389.90 | 6 | Regeneron Pharmaceuticals, Inc. ($149.97) |
| 2022 | $374.99 | 3 | Genentech USA, Inc. ($150.00) |
| 2021 | $139.89 | 2 | Johnson & Johnson Surgical Vision, Inc. ($117.76) |
| 2020 | $366.67 | 6 | Alimera Sciences, Inc. ($319.23) |
| 2019 | $1,222 | 18 | Novartis Pharmaceuticals Corporation ($419.13) |
| 2018 | $238.29 | 3 | Allergan Inc. ($130.58) |
| 2017 | $1,960 | 5 | Alcon Laboratories Inc ($1,169) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/09/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: IMMUNOLOGY | ||||||
| 08/28/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $30.66 | General |
| Category: IMMUNOLOGY | ||||||
| 07/07/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Ophthalmology | ||||||
| 10/17/2023 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $149.97 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/05/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/29/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/27/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/19/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: Immunology and Ophthalmology | ||||||
| 02/10/2023 | Rayner Intraocular Lenses Limited | RayOne EMV (Device), RayOne Spheric, RayOne Aspheric | Food and Beverage | Cash or cash equivalent | $49.72 | General |
| Category: Ophthalmology | ||||||
| 11/08/2022 | Regeneron Pharmaceuticals, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/06/2022 | Genentech USA, Inc. | Erivedge (Biological) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: BioOncology | ||||||
| 04/07/2022 | ABBVIE INC. | VUITY (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/01/2021 | Johnson & Johnson Surgical Vision, Inc. | Tecnis IOL (Device) | Food and Beverage | In-kind items and services | $117.76 | General |
| Category: Optics | ||||||
| 02/26/2021 | Aerie Pharmaceuticals, Inc. | rocklatan (Drug), rhopressa | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Glaucoma | ||||||
| 12/21/2020 | Bausch & Lomb, a division of Bausch Health US, LLC | LOTEMAX SM (Drug), VYZULTA, BEPREVE | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/11/2020 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/12/2020 | Alimera Sciences, Inc. | Iluvien (Drug) | Food and Beverage | Cash or cash equivalent | $113.57 | General |
| Category: Ophthalmology | ||||||
| 07/31/2020 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug), LOTEMAX SM | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/10/2020 | Alimera Sciences, Inc. | Iluvien (Drug) | Food and Beverage | Cash or cash equivalent | $192.79 | General |
| Category: Ophthalmology | ||||||
| 02/03/2020 | Alimera Sciences, Inc. | Iluvien (Drug) | Food and Beverage | Cash or cash equivalent | $12.87 | General |
| Category: Ophthalmology | ||||||
| 12/04/2019 | Novartis Pharmaceuticals Corporation | BEOVU (Drug) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/14/2019 | Alimera Sciences, Inc. | Iluvien (Drug) | Food and Beverage | Cash or cash equivalent | $134.22 | General |
| Category: Ophthalmology | ||||||
| 09/23/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | LOTEMAX SM (Drug), BEPREVE, ALREX | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/05/2019 | Allergan Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: RETINA | ||||||
| 08/16/2019 | Vyera Pharmaceuticals, LLC | Daraprim 30 Tablet in 1 Bottle (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Toxoplasmosis | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 706 | 1,568 | $630,750 | $189,580 |
| 2022 | 9 | 526 | 1,156 | $459,009 | $141,320 |
| 2021 | 7 | 370 | 522 | $122,624 | $28,229 |
| 2020 | 4 | 227 | 342 | $57,890 | $16,308 |
Total Patients
1,829
Total Services
3,588
Medicare Billing
$375,437
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 20 | 166 | $207,500 | $112,918 | 54.4% |
| 67028 | Injection of drug into eye | Office | 2023 | 66 | 291 | $216,729 | $24,166 | 11.2% |
| 92134 | Imaging of retina | Office | 2023 | 200 | 488 | $92,815 | $13,827 | 14.9% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 42 | 152 | $22,800 | $9,555 | 41.9% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 85 | 129 | $19,545 | $8,005 | 41.0% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 72 | 92 | $21,800 | $6,107 | 28.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 65 | 76 | $15,194 | $5,281 | 34.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $6,900 | $2,827 | 41.0% |
| 92250 | Photography of the retina | Office | 2023 | 75 | 77 | $7,646 | $2,208 | 28.9% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 16 | 16 | $8,000 | $1,472 | 18.4% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 16 | 16 | $4,340 | $1,468 | 33.8% |
| 92014 | Established patient complete exam of visual system | Facility | 2023 | 15 | 23 | $6,417 | $1,376 | 21.4% |
| 92134 | Imaging of retina | Facility | 2023 | 11 | 19 | $1,064 | $369.17 | 34.7% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 16 | 116 | $145,000 | $83,199 | 57.4% |
| 67028 | Injection of drug into eye | Office | 2022 | 61 | 216 | $157,031 | $17,635 | 11.2% |
| 92134 | Imaging of retina | Office | 2022 | 161 | 359 | $62,935 | $10,030 | 15.9% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 99 | 132 | $31,936 | $8,740 | 27.4% |
| J7999 | Compounded drug, not otherwise classified | Office | 2022 | 36 | 114 | $17,100 | $7,466 | 43.7% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 60 | 94 | $14,334 | $6,002 | 41.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $6,000 | $2,642 | 44.0% |
| 92014 | Established patient complete exam of visual system | Facility | 2022 | 22 | 40 | $11,337 | $2,019 | 17.8% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 17 | 17 | $4,747 | $1,702 | 35.8% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 15 | 15 | $6,687 | $1,333 | 19.9% |
| 92134 | Imaging of retina | Facility | 2022 | 19 | 33 | $1,902 | $552.44 | 29.0% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 84 | 115 | $29,260 | $8,121 | 27.8% |
About Dr. Mallika Doss, MD
Dr. Mallika Doss, MD is a Retina Specialist healthcare provider based in Metairie, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2012. The National Provider Identifier (NPI) number assigned to this provider is 1184970220.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mallika Doss, MD has received a total of $4,764 in payments from pharmaceutical and medical device companies, with $72.14 received in 2024. These payments were reported across 46 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($3,335).
As a Medicare-enrolled provider, Doss has provided services to 1,829 Medicare beneficiaries, totaling 3,588 services with total Medicare billing of $375,437. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Retina Specialist
- Other Specialties Ophthalmology, Ophthalmology
- Location Metairie, LA
- Active Since 07/26/2012
- Last Updated 11/08/2021
- Taxonomy Code 207WX0107X
- Entity Type Individual
- NPI Number 1184970220
Products in Payments
- Iluvien (Drug) $548.12
- DUREZOL (Drug) $276.55
- EYLEA HD (Biological) $274.97
- OZURDEX (Drug) $255.57
- Erivedge (Biological) $150.00
- EYLEA (Biological) $137.81
- LOTEMAX SM (Drug) $131.12
- LUMIGAN (Drug) $124.67
- Tecnis IOL (Device) $117.76
- VUITY (Drug) $100.00
- LOTEMAX (Drug) $96.20
- OMIDRIA (Drug) $78.81
- Vabysmo (Drug) $65.21
- ACTHAR (Biological) $52.80
- RayOne EMV (Device) $49.72
- rocklatan (Drug) $22.13
- Syfovre (Drug) $19.34
- VYZULTA (Drug) $17.03
- Daraprim 30 Tablet in 1 Bottle (Drug) $15.25
- TRAVATAN Z (Drug) $14.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.